- Home
- EDBL vs TOVX Comparison
EDBL vs TOVX Comparison
Compare EDBL & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDBL
- TOVX
- Stock Information
- Founded
- EDBL 2020
- TOVX 2001
- Country
- EDBL United States
- TOVX United States
- Employees
- EDBL N/A
- TOVX N/A
- Industry
- EDBL Farming/Seeds/Milling
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- EDBL Consumer Staples
- TOVX Health Care
- Exchange
- EDBL Nasdaq
- TOVX Nasdaq
- Market Cap
- EDBL 4.0M
- TOVX 3.8M
- IPO Year
- EDBL 2022
- TOVX 2006
- Fundamental
- Price
- EDBL $1.16
- TOVX $0.21
- Analyst Decision
- EDBL
- TOVX Hold
- Analyst Count
- EDBL 0
- TOVX 1
- Target Price
- EDBL N/A
- TOVX N/A
- AVG Volume (30 Days)
- EDBL 81.4K
- TOVX 4.6M
- Earning Date
- EDBL 11-14-2025
- TOVX 11-12-2025
- Dividend Yield
- EDBL N/A
- TOVX N/A
- EPS Growth
- EDBL N/A
- TOVX N/A
- EPS
- EDBL N/A
- TOVX N/A
- Revenue
- EDBL $12,553,000.00
- TOVX N/A
- Revenue This Year
- EDBL $29.56
- TOVX N/A
- Revenue Next Year
- EDBL $20.00
- TOVX N/A
- P/E Ratio
- EDBL N/A
- TOVX N/A
- Revenue Growth
- EDBL N/A
- TOVX N/A
- 52 Week Low
- EDBL $1.05
- TOVX $0.20
- 52 Week High
- EDBL $13.50
- TOVX $2.08
- Technical
- Relative Strength Index (RSI)
- EDBL 30.59
- TOVX 36.54
- Support Level
- EDBL $1.06
- TOVX $0.20
- Resistance Level
- EDBL $1.33
- TOVX $0.30
- Average True Range (ATR)
- EDBL 0.12
- TOVX 0.02
- MACD
- EDBL -0.03
- TOVX -0.00
- Stochastic Oscillator
- EDBL 15.20
- TOVX 14.51
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.